Compound ID | 762
PD 155392
Class: Small molecule antibacterial agent
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Protein synthesis inhibitor |
| Target Pathogen: | Active against Streptococcus pyogenes and Staphylococcus aureus |
| Description: | Boxazomycin derivative; Song Y, Domagala JM, Turner WR, et al. Boxazomycin analogues as new antibacterial agents synthesis and structure-activity relationships. 35th-Intersci-Conf-Antimicrobial-Agents-Chemother 1995; 116. |
| Institute where first reported: | Parke Davis Pharmaceutical Research (Pfizer, USA) |
| Year first mentioned: | 1995 |
| Development status: | Experimental |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.